vabysmo 6mg/0.05ml sol. for intravitreal inj. vial
فابيسمو 6 مجم/0.05 مل فيال
faricimabThe published official price. Pharmacies may differ slightly.
- Strength
- 6mg/0.05ml
- Form
- vial
- Manufacturer
- f.hoffman la roche
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Used for neovascular age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion.
Do not use if
Ocular or periocular infection, active intraocular inflammation, or hypersensitivity to the drug.
Side effects
May cause increased intraocular pressure, eye discomfort, conjunctival hemorrhage, endophthalmitis, retinal detachment, or hypersensitivity reactions.
Warnings
Patients should promptly report symptoms of infection, retinal detachment, or vision changes after intravitreal injection.
How it works
Bispecific monoclonal antibody that inhibits VEGF-A and Ang-2 pathways, reducing vascular leakage and abnormal blood vessel growth.
Storage
Store refrigerated at 2°C–8°C. Do not freeze or shake.